Boehringer aims for new Pradaxa use in hip surgery; Merck asks judge to toss Integrilin marketing claims;

@FiercePharma: What's Next For The Thousands Of Angry Men Suing Over Testosterone? Forbes article | Follow @FiercePharma

@CarlyHFierce: ICYMI: Pfizer shutters vaccine sales business in China after Prevenar setback. Story | Follow @CarlyHFierce

> The FDA accepted Boehringer Ingelheim's application for broader use of its anticoagulant Pradaxa, to prevent deep vein thrombosis and pulmonary embolism after hip replacement surgery. Release

> Merck & Co. ($MRK) asked a California judge to dismiss whistleblower claims in a lawsuit over its marketing of the drug Integrilin, after similar claims against its partner Millennium were tossed out. Report (sub. req.)

> Teva Pharmaceutical Industries ($TEVA) struck a $24 million deal to escape a Nexium pay-for-delay suit. Report (sub. req.)

> Juno Therapeutics ($JUNO) settled a patent fight with Novartis ($NVS) and the University of Pennsylvania, over a deal that includes a $12.25 million up-front payment from the drugmaker and future milestones and royalties on any related drugs eventually approved. Release

> As their pharma exports slump, Australian drugmakers are seeking government incentives to boost their competitiveness in other countries. Report

> An antibiotic-resistant strain of the gastrointestinal bacteria shigella is spreading in the U.S. Report (sub. req.)

Medical Device News

@FierceMedDev: Check out the top med tech companies of 2014. Feature | Follow @FierceMedDev

@StacyALawrence: ICYMI: FDA to investigate Bayer's birth control device after allegations of trial fraud. Story | Follow @StacyALawrence

@VarunSaxena2: ICYMI: Medtronic tries again in renal denervation after previous trial failure. Article | Follow @VarunSaxena2

@EmilyWFierce: Medtronic grabs artificial pancreas tech from Israeli devicemaker. Report | Follow @EmilyWFierce

> U.S. health insurers consider new curbs on morcellators amid regulatory pushback. Article

> Medtronic pays feds $4.4 million over DOJ allegations that it falsely labeled devices as made in the USA. Story

Biotech News

@FierceBiotech: ICYMI: GlaxoSmithKline to create new vaccines hub, uprooting groups in Cambridge, Philly. Report | Follow @FierceBiotech

@JohnCFierce: You rarely see a real battle to the death in biotech over patents. Usually, it all gets down to a reasonable set of numbers. | Follow @JohnCFierce

> MorphoSys: That Celgene-abandoned cancer drug isn't dead yet. Report

> Juno and Novartis settle CAR-T patent fight with little fanfare. More

> Bristol-Myers bets big on gene therapy with a $1B uniQure deal. Article

Animal Health News

> TVAX pours $2M funding round into canine osteosarcoma drug. More

> UN launches global campaign to wipe out ruinous sheep and goat virus. Article

> Under pressure, Zoetis pulls arsenic-based poultry drug from market. News

> Homeland Security names program manager for new NBAF facility in Kansas. Story

> Texas Tech scientists discover that antibiotic-resistant bugs from cattle lots are airborne. Report

Biotech IT News

> Celgene, Genentech back clinical trial enrollment challenge. News

> Potency prediction software helps Schrödinger land $120M Sanofi deal. Report

> Genentech begins search for bioinformatics chief after Gentleman leaves for 23andMe. Story

> 23andMe-style sequencing project taps Facebook in pursuit of 20,000 participants. Article

> Genome Canada makes $24M pivot to bolster bioinformatics capabilities. More

And Finally... Statin drugs can have some sexual side effects, good and bad, experts point out. Report